Synopsys, Inc. $SNPS Shares Sold by Glenmede Trust Co. NA

Key Points

• Glenmede Trust reduced its Synopsys position by 17.8% in the first quarter, selling 3,173 shares and retaining 14,609 shares valued at approximately $5.8 million.
• Institutional ownership remains high at 85.47%, with investors including Bank of America and CCM Investment Advisers increasing their stakes, while Synopsys’ CFO and CEO sold shares under pre-arranged Rule 10b5-1 plans.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and a $570.06 target price. Synopsys also exceeded quarterly EPS and revenue estimates, reporting $2.28 billion in revenue, up 41.9% year over year.

Glenmede Trust Co. NA decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 17.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,609 shares of the semiconductor company's stock after selling 3,173 shares during the quarter. Glenmede Trust Co. NA's holdings in Synopsys were worth $5,792,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Essential Partners LLC purchased a new position in Synopsys during the 1st quarter worth approximately $50,000. CCM Investment Advisers LLC increased its stake in shares of Synopsys by 23.9% in the first quarter. CCM Investment Advisers LLC now owns 31,137 shares of the semiconductor company's stock worth $12,345,000 after acquiring an additional 6,009 shares during the period. Western Wealth Management LLC acquired a new stake in shares of Synopsys in the first quarter worth $131,000. Bank of America Corp DE raised its holdings in shares of Synopsys by 34.0% during the first quarter. Bank of America Corp DE now owns 1,386,817 shares of the semiconductor company's stock worth $549,845,000 after purchasing an additional 352,004 shares during the last quarter. Finally, Intrinsic Edge Capital Management LLC lifted its position in Synopsys by 10.0% during the first quarter. Intrinsic Edge Capital Management LLC now owns 11,000 shares of the semiconductor company's stock valued at $4,361,000 after purchasing an additional 1,000 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Bank of America upped their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Morgan Stanley lifted their price objective on Synopsys from $480.00 to $525.00 and gave the company an "equal weight" rating in a research note on Thursday, May 28th. Zacks Research raised Synopsys from a "hold" rating to a "strong-buy" rating in a report on Tuesday, June 30th. Berenberg Bank set a $633.00 target price on Synopsys in a research note on Wednesday, May 27th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $580.00 target price on shares of Synopsys in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $570.06.

Synopsys Price Performance

NASDAQ:SNPS opened at $392.07 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $636.61. The stock's 50-day moving average price is $441.23 and its 200-day moving average price is $449.25. The stock has a market capitalization of $75.07 billion, a PE ratio of 90.76, a price-to-earnings-growth ratio of 2.28 and a beta of 1.22.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the prior year, the business posted $3.67 earnings per share. Synopsys's revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source